De Brauw assisted Aalberts N.V. (Aalberts) with reaching an agreement with Grand Venture Technology Limited (GVT) on the proposed 100% acquisition and delisting of GVT from the Singaporean stock exchange. GVT is a leading precision engineering solutions and service provider of components, mechatronics, assembly and testing mainly for semiconductor, analytical life sciences, medical, aerospace and industrial automation industries, which, with its head office in Singapore, operates 6 facilities across Singapore, Malaysia and China.

De Brauw assisted Akzo Nobel N.V. on the sale of its shareholding in Akzo Nobel India Limited ("ANIL") to the JSW Group, one of India's leading diversified conglomerates. The transaction is based on a total enterprise value of approx. EUR 1.4 billion and includes AkzoNobel's liquid paints and coatings business in India. The India Powder Coatings business and International Research Center, both currently part of ANIL, will be retained by AkzoNobel under full ownership.

De Brauw assisted Akzo Nobel N.V. on the sale of its shareholding in Akzo Nobel India Limited ("ANIL") to the JSW Group, one of India's leading diversified conglomerates. The transaction is based on a total enterprise value of approx. EUR 1.4 billion and includes AkzoNobel's liquid paints and coatings business in India. The India Powder Coatings business and International Research Center, both currently part of ANIL, will be retained by AkzoNobel under full ownership.

De Brauw advised Collibra B.V., a leading company in unified governance for data and AI, on its acquisition of the Belgian company Raito BV, which specializes in data access governance. Through this transaction, Collibra aims to demonstrate its ongoing commitment to unifying and automating data and AI governance for all data users across various data sources. This initiative is designed to help organizations accelerate their use of data and AI with confidence.

De Brauw advised Bugaboo on the acquisition of Joolz, a high-quality stroller brand. Closing of the transaction is subject to customary conditions.

De Brauw has advised Royal Schiphol Group, a Dutch airport management company, on its joint venture with Lagardère Travel Retail, a France-based global travel retailer

De Brauw advised Achmea Pensioen & Levensverzekeringen N.V. on expanding its existing pension services to FrieslandCampina through a buy-out.

De Brauw has advised Royal Schiphol Group, a Dutch airport management company, on its joint venture with Lagardère Travel Retail, a France-based global travel retailer

CitizenM is a leading hotel operator under the citizenM brand and a fully integrated global hotel real estate developer, currently operating and developing hotels in more than 20 cities in North America, Europe, and Asia. De Brauw has acted as counsel to citizenM Holding B.V., in collaboration with Kirkland & Ellis LLP, for the sale of the citizenM brand and related IP assets to Marriott Worldwide Corporation through an asset purchase agreement.

B&S Group S.A., active in the consumer goods industry, and Sarabel have reached conditional agreement on an envisaged recommended public offer by Sarabel, trough its affiliate ELFB Investments Netherlands B.V., for all issued and outstanding shares in the capital of B&S of EUR 6.15 (cum dividend) in cash per share. The offer values a 100% of the shares at approximately EUR 518 million and is unanimously recommended by the executive board and supervisory board of B&S.

On 28 March 2025, Dutch newspaper Trouw published a front page article on systemic failures in medical care for detained women. That same day, Bureau Clara Wichmann presented a report to the Dutch State Secretary for Justice and Security describing how over 50 detained women had not been given adequate medical care, sometimes resulting in severe damage to their health, even death. Detainee testimonies reveal that medical complaints are often dismissed, access to specialised care is insufficient, and the process of dispensing medication is prone to errors. Additionally, gender-sensitive care is lacking, and the absence of continuity in medical treatment poses severe health risks. The issue was also discussed in many other media outlets, including on Radio 1 (NOS Met het Oog op Morgen – [NOS Met het Oog op Morgen - Beluister Met het Oog op Morgen 27-03-2025 | Podcasts | NPO Radio 1], minute 11.40).

De Brauw has acted as lead counsel to Exor on a EUR 1 billion share buyback tender offer. The tender offer will be executed via a reverse "Dutch auction", allowing qualifying shareholders to select the price at which they wish to sell their shares back to Exor within a pre-determined price range, extending in 1% increments, from a 3% discount to a 10% premium over a VWAP reference price. The tender offer is supported by Exor majority shareholder Giovanni Agnelli B.V., which has committed to participate for an amount of up to EUR 250 million at whatever price is ultimately determined to be the strike price (as a 'strike price tender'). As trusted lead legal adviser to Exor, De Brauw was involved in all strategic and legal aspects of the tender offer, the majority shareholder commitment, and the drafting of documentation including the offer memorandum.